Annexon, Inc. (ANNX) vs Faeth Therapeutics, Inc. (FTH)
A side-by-side comparison of Annexon, Inc. and Faeth Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANNX
Annexon, Inc.
$4.20HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
FTH
Faeth Therapeutics, Inc.
$27.10HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ANNX vs FTH
growth of $100 · dividends reinvested · last 6yANNX -82.0% (-24.9%/yr)FTH -92.8% (-35.5%/yr)ANNX compounded faster over this window
ANNX FTH
ANNX vs FTH: by the numbers
- •FTH is the larger company ($699M vs $688M market cap).
Metrics side by side
Valuation
| Metric | ANNX | FTH |
|---|---|---|
| P/B ratio | 3.70 | 4.04 |
Profitability
| Metric | ANNX | FTH |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -108.93% | -113.05% |
| ROIC | -101.43% | -110.62% |
Growth (annualized)
| Metric | ANNX | FTH |
|---|---|---|
| Total return CAGR (5Y) | -26.29% | -31.75% |
Frequently asked
- How have ANNX and FTH total returns compared?
- Over the past 5 years, ANNX delivered -26.29% and FTH delivered -31.75% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.